Antonella Bandiera

Evaluation of a cathelicidin derivative fusion polypeptide for pathogen-targeted antimicrobial approach

Abstract The human cathelicidin LL-37 is one of the most promising candidates for replacing standard antibiotics due to its broad-spectrum activity and low propensity for resistance development. However, the widespread clinical adoption of antimicrobial peptides (AMPs) is current...